Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective,

Nicolas M Intagliata1, Robert S Rahimi2, Fatima Higuera-de-la-Tijera3

  • 1University of Virginia Health System, Charlottesville, Virginia.

Gastroenterology
|June 4, 2023
PubMed

Insights

Procedural bleeding in hospitalized cirrhosis patients is rare but serious. High-risk procedures, elevated BMI, and advanced liver disease predict bleeding events, not standard tests.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Hospitalized patients with cirrhosis often require multiple procedures.
  • The risk and management of procedural bleeding in this population are not well-defined.

Purpose of the Study:

  • To determine the incidence of procedural-related bleeding in hospitalized cirrhosis patients.
  • To identify independent risk factors for bleeding events.

Main Methods:

  • An international, prospective, multicenter study involving 1187 patients undergoing 3006 nonsurgical procedures.
  • Patients were monitored for 28 days post-admission or until a major event.

Main Results:

  • Bleeding occurred in 6.9% of patient admissions and 3.0% of procedures; major bleeding in 2.3% and 0.9%, respectively.
  • High-risk procedures, elevated Model for End-Stage Liver Disease (MELD) score, and higher Body Mass Index (BMI) independently predicted bleeding.
  • Conventional hemostasis tests, prophylaxis, and antithrombotics were not predictive.

Conclusions:

  • Procedural bleeding is infrequent in hospitalized cirrhosis patients.
  • Patients with higher BMI and decompensated liver disease undergoing high-risk procedures face increased bleeding risk.
  • Bleeding risk is not reliably predicted by standard tests or prophylaxis.
Abstract